| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |